Abstract | BACKGROUND: METHODS: Thirty-five patients with Mallory-Weiss syndrome with spurting vessels or oozing in a university hospital were enrolled prospectively and randomly assigned to endoscopic hemoclip placement (18 patients) or endoscopic epinephrine injection (17 patients) performed by 4 endoscopists with similar clinical experiences. Demographic characteristics, endoscopic variables, and outcome parameters as well as rates of hemostasis and recurrent bleeding were analyzed. RESULTS: The mean (SD) number of hemoclips applied was 2.5 (1.2) and the mean volume of injection was 7.9 (4.3) mL. Primary hemostasis was achieved in all 35 patients. In each group there was 1 case of recurrent bleeding. Secondary hemostasis was achieved by repeating the same procedures as at randomization in both cases. There were no significant differences in age, gender, prior ingestion of alcohol, presenting symptoms, hemoglobin level, shock, comorbid diseases, bleeding stigmata, tear location, blood transfusion, or hospitalization between the groups. There were no procedure-related complications in either group; surgery was not required in any patient. For both groups, there were no second episodes of recurrent bleeding, procedure-related complication, or need of operation. CONCLUSION:
|
Authors | Shih-Pei Huang, Hsiu-Po Wang, Yi-Chia Lee, Chun-Che Lin, Chang-Shiu Yang, Ming-Shiang Wu, Jaw-Town Lin |
Journal | Gastrointestinal endoscopy
(Gastrointest Endosc)
Vol. 55
Issue 7
Pg. 842-6
(Jun 2002)
ISSN: 0016-5107 [Print] United States |
PMID | 12024138
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Vasoconstrictor Agents
- Epinephrine
|
Topics |
- Adult
- Aged
- Endoscopy, Digestive System
(adverse effects)
- Epinephrine
(administration & dosage, adverse effects, therapeutic use)
- Esophageal Diseases
(etiology, pathology, therapy)
- Female
- Hemorrhage
(etiology, pathology, therapy)
- Humans
- Injections
- Male
- Mallory-Weiss Syndrome
(complications, pathology, therapy)
- Middle Aged
- Outcome Assessment, Health Care
- Prospective Studies
- Surgical Instruments
(adverse effects)
- Vasoconstrictor Agents
(administration & dosage, adverse effects, therapeutic use)
|